Gilead Sciences Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product With Yeztugo® (Lenacapavir)

Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has been awarded the prestigious 2025 Prix Galien USA Award for Best ...
Fierce Biotech

Gilead ends phase 1 trial after settling on twice-yearly treatment partner for lenacapavir

Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...
sharewise

GILD Q3 Earnings and Sales Beat Estimates, HIV and Livdelzi Sales Grow

Gilead Sciences, Inc. GILD posted better-than-expected third-quarter 2025 results and lifted the lower end of its product ...

Gilead GILD Q3 2025 Earnings Call Transcript

Seven, starting on Slide third quarter product sales excluding Victory were $7.1 billion, 4% year over year up Including ...
Le Lézard

Nootropics Depot Advances Supplement Science with Unmatched Research and Development

Nootropics Depot is redefining the landscape of dietary supplements through its uncompromising research and development (R&D) initiatives. By integrating advanced laboratory technology, rigorous ...

Gilead Sciences, Inc. (GILD) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...
Le Lézard

/R E P E A T -- Notice to the media - Government of Canada to announce funding to help address the toxic drug and overdose crisis in the Northwest Territories/

The Honourable Rebecca Alty, Minister of Crown-Indigenous Relations and Member of Parliament for Northwest Territories, on behalf of the Honourable Marjorie Michel, Minister of Health, will make an ...